Our previous study verified that CM derived from fibroblasts (18Co) or CAFs enhanced sphere-formation capability and tumorigenicity in CD133+/hi CSCs [8], suggesting that both mechanisms (i.e., maintaining the CSC pool and reprogramming differentiated CRC cells to CSCs) may cooperate to confer chemoresistance. The gene discussed is PROM1; the disease is colorectal carcinoma.